W41 (Rosiglitazone maleate 2 mg (base))
Pill imprint W41 has been identified as Rosiglitazone maleate 2 mg (base).
Rosiglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 2 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
More about rosiglitazone
- Other brands: Avandia
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.